COMP <GO>
PHG vs LLY // PIOTROSKI F-SCORE QUALITY
Koninklijke Philips N.V. NY Registry Shares (NYSE) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: PHG 3
— LLY 12
▲ PIOTROSKI F-SCORE QUALITY LEADER: LLY
LAST: $26.92 (-0.74%) • MKT CAP: $26.66B
piotroski-score
8/9
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
piotroski-score
9/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PHG VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PHG | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 83.64% | -42.64 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 32.36% | -22.46 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.0x | 36.4x | -15.42 | PHG | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | 2.30% | -0.09 | LLY | /fcf-yield <GO> |
| Operating Margin | 13.90% | 40.21% | -26.31 | LLY | /operating-margins <GO> |
| Net Profit Margin | 10.90% | 31.90% | -21.00 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 22.00% | 45.51% | -23.51 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.74 | 9.29 | -5.55 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 8/9 | 9/9 | -1.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.77% | -0.07 | PHG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.4 | 77.9 | -12.49 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 0.51 | +0.42 | PHG | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.6x | 26.3x | +1.35 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $26.66B | $1.33T | -$1.31T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PHG REV | LLY REV | PHG GROSS % | LLY GROSS % | PHG FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $65.18B | — | 83.0% | — | $16.81B |
| FY 2024 | — | $45.04B | — | 81.3% | — | $8.82B |
| FY 2023 | — | $34.12B | — | 79.3% | — | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PHG // BETA 0.93
LLY // BETA 0.51